Evidence map›Paper›PMID 32356774›Full record

ArticleJMIR research protocols2020

Effectiveness of a Quit Vaping Text Message Program in Promoting Abstinence Among Young Adult E-Cigarette Users: Protocol for a Randomized Controlled Trial.

Amanda L Graham, Megan A Jacobs, Michael S Amato, Sarah Cha, Mia M Bottcher, George D Papandonatos

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04251273 (A Randomized Trial of a Text Message Quit Vaping Intervention for Young Adults), which is not on this map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04251273 nacompletednot on this map

A Randomized Trial of a Text Message Quit Vaping Intervention for Young Adults

TypeinterventionalSponsorTruth InitiativeRan2019 to 2020Enrolled2,588ConditionsTobacco CessationArmsThis is Quitting, Assessment only Control
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Interventions for quitting vaping.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Interventions for quitting vaping.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Pooled it
  5. Trial
  6. Barriers to quittingPreventive medicine reports · 2026
    Article
  7. Review
  8. Keep e-cigarette vaping away from juveniles: immediate interventions.European respiratory review : an official journal of the European Respiratory Society · 2025
    Article
  9. Co-designing a Vaping Cessation Program for Australian Young Adults: A Conceptual Model.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
  17. Article
  18. Article
  19. Engaging Rural High School Youth in E-cigarette Prevention and Advocacy.Online journal of interprofessional health promotion · 2021
    Article
  20. Young Adults' Vaping, Readiness to Quit, and Recent Quit Attempts: The Role of Co-use With Cigarettes and Marijuana.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amanda L GrahamInnovations Center, Truth Initiative, Washington, DC, United States.ORCID https://orcid.org/0000-0003-3036-9653
Megan A JacobsInnovations Center, Truth Initiative, Washington, DC, United States.ORCID https://orcid.org/0000-0001-6526-964X
Michael S AmatoInnovations Center, Truth Initiative, Washington, DC, United States.ORCID https://orcid.org/0000-0002-9769-957X
Sarah ChaInnovations Center, Truth Initiative, Washington, DC, United States.ORCID https://orcid.org/0000-0003-3505-3164
Mia M BottcherInnovations Center, Truth Initiative, Washington, DC, United States.ORCID https://orcid.org/0000-0003-0057-7646
George D PapandonatosCenter for Statistical Sciences, Brown University, Providence, RI, United States.ORCID https://orcid.org/0000-0001-6770-932X
American Legacy Foundation · USBrown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMillions of young adults currently vape electronic cigarettes (e-cigarettes), yet little research on vaping cessation interventions exists. Text messaging is a promising, scalable intervention strategy for delivering vaping cessation treatment.

objectiveThis study evaluates the effectiveness of a text message quit vaping program (This is Quitting) in promoting abstinence from e-cigarettes among young adults; examines changes in self-efficacy, perceived social norms, and social support for quitting as hypothesized mediators of effectiveness; and examines if treatment effectiveness is moderated by gender, race, ethnicity, or sexual minority status.

methodsOverall, 2600 young adult (aged 18-24 years) e-cigarette users in the United States will be recruited via web advertisements to participate in the study. Participants will be randomized to This is Quitting or an assessment-only control condition. The primary outcome measure is 30-day vaping abstinence at 7 months post enrollment.

resultsStudy recruitment began on December 18, 2019, and is projected to be completed by spring 2020. The final 7-month follow-up is anticipated to be completed by fall/winter 2020. Because this is the first-ever evaluation of a quit vaping program, we were unable to draw on existing literature to determine the appropriate sample size. Therefore, we examined abstinence rates among an initial pilot sample of 269 participants (This is Quitting: n=148 and control: n=121) who completed the 1-month follow-up to determine the final sample size. The 1-month response rate was 79.2% (213/269), with no difference between arms. Using intention-to-treat analyses that counted nonresponders as still vaping, 30-day abstinence rates were 16.2% (24/148) among those randomized to This is Quitting and 8.3% (10/121) among those randomized to control. A treatment difference of 16% vs 8% is detectable with 80% power at 2-sided alpha=.05 with 260/group (520 total). To detect treatment differences of this magnitude in a 20% subsample (eg, Hispanic or sexual minority young adult e-cigarette users), we will enroll 1300/group (2600 total).

conclusionsThe scientific, clinical, and public health communities are desperate for cessation resources to address vaping among young people. This study is the first-ever comparative effectiveness trial of an intervention to help young people quit vaping. It focuses on evaluating the effectiveness of a theory-grounded, empirically informed text message intervention among young adults. The study is fully powered to examine potentially important subgroup differences among young people who are more vulnerable to e-cigarette use. Although potentially more challenging from a research ethics and pragmatic standpoint, evaluating quit vaping intervention approaches in teens is an important area for future research. Data from this trial will establish a benchmark of effectiveness for other vaping cessation programs and begin to create a body of evidence focused on how best to help young people break free from e-cigarettes.

trial registrationClinicalTrials.gov NCT04251273; https://clinicaltrials.gov/ct2/show/NCT04251273. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/18327.

Indexed as

e-cigarettestelehealthtext messagingtobacco cessationyoung adults

Identifiers

PMID32356774
PMCPMC7229526
OpenAlexW3012654067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.